P4HB and leukemia: Together, our data indicate a divergent effect of PDI inhibition on normal versus leukemic T cells, as E64FC26 promotes viability and suppresses UPR in healthy CD8 T cells, but induces UPR and cell death in human T cell lymphoma and leukemia cell lines.